BWP
RPRX

Baldwin Wealth Partners’s Repros Therapeutics Inc. RPRX Stock Holding History

Baldwin Wealth Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,750
Closed -$1K – 531
2017
Q4 		$1K Hold
1,750
– – ﹤0.01% 469
2017
Q3 		$1K Hold
1,750
– – ﹤0.01% 477
2017
Q2 		$1K Hold
1,750
– – ﹤0.01% 470
2017
Q1 		$2K Hold
1,750
– – ﹤0.01% 480
2016
Q4 		$2K Hold
1,750
– – ﹤0.01% 494
2016
Q3 		$4K Hold
1,750
– – ﹤0.01% 497
2016
Q2 		$3K Hold
1,750
– – ﹤0.01% 434
2016
Q1 		$2K Buy
+1,750
New +$1.71K ﹤0.01% 472

Baldwin Wealth Partners's RPRX Position: Q1 2018 in Review

Baldwin Wealth Partners sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 1,750 shares — an estimated $1K sold.

Baldwin Wealth Partners first reported a position in RPRX in Q1 2016 and held it in 8 quarters. The position peaked at $4K in Q3 2016. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Baldwin Wealth Partners reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Baldwin Wealth Partners sold 1,750 Repros Therapeutics Inc. shares in Q1 2018, an estimated $1K.
  • Baldwin Wealth Partners first reported a position in Repros Therapeutics Inc. in Q1 2016 and held it in 8 quarters.
  • Baldwin Wealth Partners's Repros Therapeutics Inc. position peaked at $4K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Baldwin Wealth Partners's 13F filing for Q1 2018, filed 16 Apr 2018.